Nazzareno Cannella

Dr. Nazzareno Cannella


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Biological Psychiatry
Verified
Journal Article
Closed access
SSSerena Stopponi
Serena Stopponi
LSLorenzo Somaini
Lorenzo Somaini
ACAndrea Cippitelli
Andrea Cippitelli
NCNazzareno Cannella
Nazzareno Cannella
SBSimone Braconi
Simone Braconi
RCRoberto Ciccocioppo
Roberto Ciccocioppo

1 February 2010 in Brain Research
Verified
Journal Article
Closed access
BBBenjamin Boutrel
Benjamin Boutrel
NCNazzareno Cannella
Nazzareno Cannella
LLLuis de Lecea
Luis de Lecea

30 April 2008 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
ACAndrea Cippitelli
Andrea Cippitelli
NCNazzareno Cannella
Nazzareno Cannella
SBSimone Braconi
Simone Braconi
ADAndrea Duranti
Andrea Duranti
ATAndrea Tontini
Andrea Tontini
RCRoberto Ciccocioppo
Roberto Ciccocioppo
A major clinical concern with the use of cannabinoid receptor 1 (CB1) direct agonists is that these compounds increase alcohol drinking and drug abuse-related behaviours. As an alternative approach, CB1-receptor-mediated activity can be facilitated by increasing anandamide levels with the use of hydrolase fatty acid amide hydrolase (FAAH) inhibitors.

25 March 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
NCNazzareno Cannella
Nazzareno Cannella
DEDaina Economidou
Daina Economidou
MKMarsida Kallupi
Marsida Kallupi
SSSerena Stopponi
Serena Stopponi
MHMarkus Heilig
Markus Heilig
RCRoberto Ciccocioppo
Roberto Ciccocioppo

25 October 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MKMarsida Kallupi
Marsida Kallupi
NCNazzareno Cannella
Nazzareno Cannella
DEDaina Economidou
Daina Economidou
MUMassimo Ubaldi
Massimo Ubaldi
BRBarbara Ruggeri
Barbara Ruggeri
RCRoberto Ciccocioppo
Roberto Ciccocioppo
Drug addiction is a chronic relapsing disorder characterized by compulsive drug seeking and use. Environmental conditioning factors are among the major determinants of relapse in abstinent cocaine users. Here we describe a role of the neuropeptide S (NPS) system in regulating relapse. In rats with a history of cocaine self-administration, presentation of stimuli predictive of drug availability reinstates drug seeking, triggering relapse. Intracerebroventricular (ICV) injection of NPS increased conditioned reinstatement of cocaine seeking, whereas peripheral administration of the NPS receptor antagonist SHA 68 reduced it. Manipulation of the NPS receptor system did not modify cocaine self-administration. We also found that ICV NPS administration activates c-Fos expression in hypocretin-1/orexin-A (Hcrt-1/Ox-A) immunoreactive neurons in the lateral hypothalamus (LH) and in the perifornical area (PeF). Of note, intra-LH and intra-PeF administration of NPS increased conditioned reinstatement of cocaine responding, an effect that was selectively blocked with the Hcrt-1/Ox-A receptor selective antagonist SB334867. Finally, results showed that intra-LH injection of the NPS antagonist [D-Cys(tBu) (5)]NPS blocked cue-induced cocaine seeking, indicating a role for this system in the pathophysiology of drug relapse.

29 March 2013 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
SSSerena Stopponi
Serena Stopponi
GGGiordano De Guglielmo
Giordano De Guglielmo
LSLorenzo Somaini
Lorenzo Somaini
ACAndrea Cippitelli
Andrea Cippitelli
NCNazzareno Cannella
Nazzareno Cannella
RCRoberto Ciccocioppo
Roberto Ciccocioppo